Clinical Trials Browser

Phase 3 × Recruiting × Resectable Colon Cancer × Clear all

NCT07412613 2026-04-22

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Phase 3 Recruiting

GastrointestinalOther solid neoplasm

Resectable Colon Cancer